---
schema_version: "secwatch.filing_event.v1"
accession: "0001628280-24-049241"
form_type: "8-K"
ticker: "AIFC"
cik: "0000862861"
company_name: "AI Financial Corp"
filed_at: "2024-11-26T23:59:59+00:00"
generated_at: "2026-05-29T18:25:31.062523+00:00"
event_type: "m_and_a"
sentiment: "neutral"
materiality_score: 0.55
calibrated_materiality_score: 0.55
confidence: "high"
source: SEC EDGAR
---

# ALT5 Sigma subsidiary signs non-binding term sheet to acquire Soin Bioscience for equity, milestones up to $60M

## Summary
- Non-binding term sheet signed Nov 19, 2024: Alyea Therapeutics to acquire 100% of Soin Bioscience from Dr. Amol Soin.
- Consideration: 10% Alyea common equity (forfeitable pre-IPO), $5M cash on first FDA approval, 5% royalty up to $40M, 10% of PRV sale proceeds up to $15M.
- Clawback: If Alyea no IPO by Dec 31, 2025, Dr. Soin can reclaim Soin Bio and Soin Thera for no consideration.
- Soin Bio's clear patch technology is investigational, pending clinical trials and FDA approval; delivers pain medication up to 8 hours.
- Binding exclusivity: Soin Bio cannot solicit other offers until Feb 28, 2025; subject to due diligence and definitive agreements.

## SEC filing metadata
- accession: 0001628280-24-049241
- form_type: 8-K
- ticker: AIFC
- cik: 0000862861
- company_name: AI Financial Corp
- filed_at: 2024-11-26T23:59:59+00:00
- event_type: m_and_a
- sentiment: neutral
- materiality_score: 0.55
- calibrated_materiality_score: 0.55
- confidence: high
- sec_items: 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/862861/000162828024049241/0001628280-24-049241-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/862861/000162828024049241/jan-20241119.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001628280-24-049241
- JSON: https://secwatch.observer/filing/0001628280-24-049241.json
- Plain text: https://secwatch.observer/filing/0001628280-24-049241.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.